155 related articles for article (PubMed ID: 20594243)
1. Prisons, prisoners, and hepatitis C.
Ferguson L; Batey R
J Gastroenterol Hepatol; 2010 Jul; 25(7):1184-6. PubMed ID: 20594243
[No Abstract] [Full Text] [Related]
2. High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C.
Bate JP; Colman AJ; Frost PJ; Shaw DR; Harley HA
J Gastroenterol Hepatol; 2010 Jul; 25(7):1276-80. PubMed ID: 20594255
[TBL] [Abstract][Full Text] [Related]
3. Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.
Manolakopoulos S; Deutsch MJ; Anagnostou O; Karatapanis S; Tiniakou E; Papatheodoridis GV; Georgiou E; Manesis E; Tzourmakliotis D; Archimandritis AJ
Liver Int; 2010 Nov; 30(10):1454-60. PubMed ID: 20846344
[TBL] [Abstract][Full Text] [Related]
4. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
Gazdag G; Horvath G; Szabo O; Ungvari GS
Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
Lucidarme D
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
[No Abstract] [Full Text] [Related]
6. Screening blood-borne virus among incarcerated inmates.
Chong VH
Int J STD AIDS; 2008 Nov; 19(11):795. PubMed ID: 18931282
[No Abstract] [Full Text] [Related]
7. Presence of hepatitis C virus in syringes confiscated in prisons in Australia.
Dolan K; Larney S; Jacka B; Rawlinson W
J Gastroenterol Hepatol; 2009 Oct; 24(10):1655-7. PubMed ID: 19788605
[TBL] [Abstract][Full Text] [Related]
8. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
[No Abstract] [Full Text] [Related]
9. Favorable outcome of acute occupational hepatitis C in healthcare workers: a multicenter French study on 23 cases.
Morin T; Pariente A; Lahmek P;
Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):515-20. PubMed ID: 21537126
[TBL] [Abstract][Full Text] [Related]
10. Acute hepatitis C virus infection in incarcerated injection drug users.
McGovern BH; Wurcel A; Kim AY; Schulze zur Wiesch J; Bica I; Zaman MT; Timm J; Walker BD; Lauer GM
Clin Infect Dis; 2006 Jun; 42(12):1663-70. PubMed ID: 16705568
[TBL] [Abstract][Full Text] [Related]
11. Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort.
Morin T; Pariente A; Lahmek P; Rabaud C; Silvain C; Cadranel JF;
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):157-66. PubMed ID: 19734798
[TBL] [Abstract][Full Text] [Related]
12. Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections.
Berzin T; Allen S; Taylor L; Rich J; Feller E
Med Health R I; 2002 Nov; 85(11):341-4. PubMed ID: 12462866
[No Abstract] [Full Text] [Related]
13. Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.
Hagan H; Latka MH; Campbell JV; Golub ET; Garfein RS; Thomas DA; Kapadia F; Strathdee SA;
Clin Infect Dis; 2006 Mar; 42(5):669-72. PubMed ID: 16447112
[TBL] [Abstract][Full Text] [Related]
14. Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age?
Matheï C; Buntinx F; Van Damme P
J Infect Dis; 2001 Sep; 184(5):659-60. PubMed ID: 11494175
[No Abstract] [Full Text] [Related]
15. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
16. [Current and future applications of viral clearance kinetics in the treatment of hepatitis C].
Buti M
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():24-9. PubMed ID: 15195531
[No Abstract] [Full Text] [Related]
17. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
[TBL] [Abstract][Full Text] [Related]
18. Enhancing hepatitis C treatment uptake and outcomes for injection drug users.
Dore GJ
Hepatology; 2007 Jan; 45(1):3-5. PubMed ID: 17187427
[No Abstract] [Full Text] [Related]
19. [Low prevalence of hepatitis C virus infection in a prisoner population from Maracaibo, Venezuela].
Monsalve-Castillo F; Chacín-Bonilla L; Atencio RJ; Porto LD; Costa-León LA; Estévez JE; Callejas-Valero DE
Biomedica; 2009 Dec; 29(4):647-52. PubMed ID: 20440463
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
Hallinan R; Byrne A; Amin J; Dore GJ
J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
